|
| 34233174 | The Plasmodium falciparum ABC transporter ABCI3 confers parasite strain-dependent pleiotropic antimalarial drug resistance. | Cell Chem Biol | 2022 |
| 35730550 | Workshop-based learning and networking: a scalable model for research capacity strengthening in low- and middle-income countries. | Glob Health Action | 2022 |
| 36422597 | Luna Virus and Helminths in Wild <i>Mastomys natalensis</i> in Two Contrasting Habitats in Zambia: Risk Factors and Evidence of Virus Dissemination in Semen. | Pathogens | 2022 |
| 36247976 | Metagenomic Pathogen Sequencing in Resource-Scarce Settings: Lessons Learned and the Road Ahead. | Front Epidemiol | 2022 |
| 33788923 | Estimation of Secondary Household Attack Rates for Emergent Spike L452R Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Variants Detected by Genomic Surveillance at a Community-Based Testing Site in San Francisco. | Clin Infect Dis | 2022 |
| 34348113 | Chemogenomics identifies acetyl-coenzyme A synthetase as a target for malaria treatment and prevention. | Cell Chem Biol | 2022 |
| 33479319 | The antimalarial efficacy and mechanism of resistance of the novel chemotype DDD01034957. | Sci Rep | 2021 |
| 33688689 | Estimation of secondary household attack rates for emergent SARS-CoV-2 variants detected by genomic surveillance at a community-based testing site in San Francisco. | medRxiv | 2021 |
| 32359426 | Inhibition of Resistance-Refractory P. falciparum Kinase PKG Delivers Prophylactic, Blood Stage, and Transmission-Blocking Antiplasmodial Activity. | Cell Chem Biol | 2020 |
| 31813848 | Combining Stage Specificity and Metabolomic Profiling to Advance Antimalarial Drug Discovery. | Cell Chem Biol | 2020 |
| 32078764 | Probing the Open Global Health Chemical Diversity Library for Multistage-Active Starting Points for Next-Generation Antimalarials. | ACS Infect Dis | 2020 |
| 33112933 | Rapid deployment of SARS-CoV-2 testing: The CLIAHUB. | PLoS Pathog | 2020 |
| 32929126 | Evaluation of whole genome amplification and bioinformatic methods for the characterization of Leishmania genomes at a single cell level. | Sci Rep | 2020 |
| 32527780 | Complete Genome Sequence of a Novel Coronavirus (SARS-CoV-2) Isolate from Bangladesh. | Microbiol Resour Announc | 2020 |
| 31830038 | Genomes of Leishmania parasites directly sequenced from patients with visceral leishmaniasis in the Indian subcontinent. | PLoS Negl Trop Dis | 2019 |
| 29326268 | Mapping the malaria parasite druggable genome by using in vitro evolution and chemogenomics. | Science | 2018 |
| 30107725 | Defining the Determinants of Specificity of Plasmodium Proteasome Inhibitors. | J Am Chem Soc | 2018 |
| 29941635 | UCT943, a Next-Generation Plasmodium falciparum PI4K Inhibitor Preclinical Candidate for the Treatment of Malaria. | Antimicrob Agents Chemother | 2018 |
| 30523084 | Open-source discovery of chemical leads for next-generation chemoprotective antimalarials. | Science | 2018 |
| 30355750 | Erratum for Brunschwig et al., "UCT943, a Next-Generation Plasmodium falciparum PI4K Inhibitor Preclinical Candidate for the Treatment of Malaria". | Antimicrob Agents Chemother | 2018 |
| 28742826 | Macromolecular biosynthetic parameters and metabolic profile in different life stages of Leishmania braziliensis: Amastigotes as a functionally less active stage. | PLoS One | 2017 |
| 28249021 | Single locus genotyping to track Leishmania donovani in the Indian subcontinent: Application in Nepal. | PLoS Negl Trop Dis | 2017 |
| 28808258 | Hexahydroquinolines are antimalarial candidates with potent blood-stage and transmission-blocking activity. | Nat Microbiol | 2017 |
| 28623350 | Multiplexed Spliced-Leader Sequencing: A high-throughput, selective method for RNA-seq in Trypanosomatids. | Sci Rep | 2017 |
| 28536289 | Modulation of Aneuploidy in <i>Leishmania donovani</i> during Adaptation to Different <i>In Vitro</i> and <i>In Vivo</i> Environments and Its Impact on Gene Expression. | mBio | 2017 |
| 26754204 | Correction to Antileishmanial Activity of a Series of N(2),N(4)-Disubstituted Quinazoline-2,4-diamines. | J Med Chem | 2016 |
| 27400870 | Alice in microbes' land: adaptations and counter-adaptations of vector-borne parasitic protozoa and their hosts. | FEMS Microbiol Rev | 2016 |
| 27003289 | Evolutionary genomics of epidemic visceral leishmaniasis in the Indian subcontinent. | Elife | 2016 |
| 25645828 | Experimental resistance to drug combinations in Leishmania donovani: metabolic and phenotypic adaptations. | Antimicrob Agents Chemother | 2015 |
| 23815683 | Drug resistance in vectorborne parasites: multiple actors and scenarios for an evolutionary arms race. | FEMS Microbiol Rev | 2014 |
| 24802998 | Treatment failure in leishmaniasis: drug-resistance or another (epi-) phenotype? | Expert Rev Anti Infect Ther | 2014 |
| 24874647 | Antileishmanial activity of a series of N²,Nâ´-disubstituted quinazoline-2,4-diamines. | J Med Chem | 2014 |
| 22950457 | Drug-resistant microorganisms with a higher fitness--can medicines boost pathogens? | Crit Rev Microbiol | 2013 |
| 24688684 | LC-MS metabolomics from study design to data-analysis - using a versatile pathogen as a test case. | Comput Struct Biotechnol J | 2013 |
| 24105765 | Relapse after treatment with miltefosine for visceral leishmaniasis is associated with increased infectivity of the infecting Leishmania donovani strain. | mBio | 2013 |
| 24020363 | Metabolic adaptations of Leishmania donovani in relation to differentiation, drug resistance, and drug pressure. | Mol Microbiol | 2013 |
| 23980130 | In vitro susceptibility of Leishmania donovani to miltefosine in Indian visceral leishmaniasis. | Am J Trop Med Hyg | 2013 |
| 23943823 | Reply to Das. | Clin Infect Dis | 2013 |
| 23808607 | Evaluation of normalization methods to pave the way towards large-scale LC-MS-based metabolomics profiling experiments. | OMICS | 2013 |
| 23425958 | Increasing failure of miltefosine in the treatment of Kala-azar in Nepal and the potential role of parasite drug resistance, reinfection, or noncompliance. | Clin Infect Dis | 2013 |
| 23480865 | (Post-) Genomic approaches to tackle drug resistance in Leishmania. | Parasitology | 2013 |
| 22119748 | Genome-wide SNP and microsatellite variation illuminate population-level epidemiology in the Leishmania donovani species complex. | Infect Genet Evol | 2012 |
| 23285309 | Treatment of visceral leishmaniasis: model-based analyses on the spread of antimony-resistant L. donovani in Bihar, India. | PLoS Negl Trop Dis | 2012 |
| 22753945 | Genetic markers for SSG resistance in Leishmania donovani and SSG treatment failure in visceral leishmaniasis patients of the Indian subcontinent. | J Infect Dis | 2012 |
| 22389733 | Molecular mechanisms of drug resistance in natural Leishmania populations vary with genetic background. | PLoS Negl Trop Dis | 2012 |
| 20678296 | Comparison of gene expression patterns among Leishmania braziliensis clinical isolates showing a different in vitro susceptibility to pentavalent antimony. | Parasitology | 2011 |
| 22038251 | Whole genome sequencing of multiple Leishmania donovani clinical isolates provides insights into population structure and mechanisms of drug resistance. | Genome Res | 2011 |
| 21829701 | Antimonial resistance in Leishmania donovani is associated with increased in vivo parasite burden. | PLoS One | 2011 |
| 21819638 | Increased metacyclogenesis of antimony-resistant Leishmania donovani clinical lines. | Parasitology | 2011 |
| 21572980 | Comparative gene expression analysis throughout the life cycle of Leishmania braziliensis: diversity of expression profiles among clinical isolates. | PLoS Negl Trop Dis | 2011 |